These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 22233336

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V, Hamon M.
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N.
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [Abstract] [Full Text] [Related]

  • 9. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [Abstract] [Full Text] [Related]

  • 10. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM, Kang TB, Hjorth S, Auerbach SB.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor.
    Okada M, Matsumoto R, Yamamoto Y, Fukuyama K.
    Int J Mol Sci; 2021 Jan 29; 22(3):. PubMed ID: 33572981
    [Abstract] [Full Text] [Related]

  • 14. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
    Chenu F, Guiard BP, Bourin M, Gardier AM.
    Behav Brain Res; 2006 Sep 25; 172(2):256-63. PubMed ID: 16806519
    [Abstract] [Full Text] [Related]

  • 15. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
    Bel N, Artigas F.
    J Pharmacol Exp Ther; 1996 Sep 25; 278(3):1064-72. PubMed ID: 8819487
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
    Dutta AK, Santra S, Sharma H, Voshavar C, Xu L, Mabrouk O, Antonio T, Reith ME.
    PLoS One; 2014 Sep 25; 9(11):e113420. PubMed ID: 25427177
    [Abstract] [Full Text] [Related]

  • 17. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.
    Mørk A, Kreilgaard M, Sánchez C.
    Neuropharmacology; 2003 Aug 25; 45(2):167-73. PubMed ID: 12842122
    [Abstract] [Full Text] [Related]

  • 18. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M.
    J Neurochem; 2003 Jul 25; 86(1):13-24. PubMed ID: 12807420
    [Abstract] [Full Text] [Related]

  • 19. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.
    Montezinho LP, Miller S, Plath N, Jensen NH, Karlsson JJ, Witten L, Mørk A.
    Psychopharmacology (Berl); 2010 Oct 25; 212(2):131-43. PubMed ID: 20676614
    [Abstract] [Full Text] [Related]

  • 20. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA, Li P.
    J Neural Transm (Vienna); 2003 Jun 25; 110(6):577-90. PubMed ID: 12768354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.